On May 9, 2024, Shanghai Vitalgen BioPharma Co., Ltd. (hereinafter referred to as “Vitalgen”) will globally publish the updated data on the phase I/II clinical trial of gene therapy product VGR-R01 in patients with Bietti crystalline dystrophy (BCD) in oral presentation form for the fi...
Thus, targeting TNFR2 by this approach offers a promising and novel treatment of cancer paradigm for patients.Methods:Safety and tolerability profile of BI-1808 as a single agent and in combination with pembrolizumab is currently being investigated in the Phase 1/2a clinical trial 19-BI-1808-01...
“The RMAT designation for P-BCMA-ALLO1, our lead program, is based on impressive early clinical data from our ongoing phase 1 study and further validates its potential to address the unmet needs of patients with relapsed/refractory multiple myeloma,...
Clinical trial: Up to now, pamapimod is still in the preclinical development stage. Reference: [1] Hill, R.? J. et al. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity. The Journal of pharmacology and experimental therapeutics...
No interim analysis of the primary endpoint will be performed because this is a minimal risk study. All members of the study team have access to de-identified data while the trial is ongoing; however, masking is preserved for the data collector and statistician. The principal investigator and ...
Comparison of the results showed the following: (1) no statistically significant findings were revealed when the different regimens were compared and (2) ... J M,Montejo,Alberola,... - 《Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America》 被引量...
- 《Clinical Drug Investigation》 被引量: 60发表: 2009年 Armodafinil as Adjunctive Therapy in Adults With Cognitive Deficits Associated With Schizophrenia: A 4-Week, Double-Blind, Placebo-Controlled Study OBJECTIVE: To evaluate the efficacy and tolerability of armodafinil, the longer-lasting isomer ...
To the extent your Personal Data constitutes “Consumer Health Data,” the categories of Consumer Health Data being collected; the manner in which it will be used; the categories of sources from which it is collected; the categories of third parties and affiliates with whom...
There were no statistically significant differences for any other parameters between the 3 groups.#These results suggest that the timing of peritonsillar infiltration with bupivacaine is not of clinical importance and does not affect the quality of postoperative analgesia in patients undergoing ...
No studies examined the impact of e-visits on healthcare access. Available studies are observational in nature and it is difficult to draw firm conclusions about effectiveness or impact on care delivery. CONCLUSIONS Overall, the evidence suggests e-visits may provide comparable clinical outcomes to ...